Exide Industries Approves ₹1,400-Crore FY27 Capex Amid Strong Q1 Performance

Market snapshot: Exide Industries Limited has approved a capital expenditure of ₹1,400 crore for FY27, which includes a ₹100 crore infusion in July 2026 into its lithium-ion cell manufacturing subsidiary, Exide Energy Solutions Limited (EESL). The company reported robust Q1 FY27 standalone earnings with a 17.6% YoY revenue increase to ₹5,305 crore, powered by seasonal inverter battery demand and OEM volume growth. Meanwhile, trial runs and sample shipments have commenced at its 6 GWh Phase 1 Bengaluru gigafactory, with management targeting 25% to 30% capacity utilization in its first year.

Data Snapshot

• Exide standalone revenue from operations grew 17.6% YoY to ₹5,305 crore in Q1 FY27
• Standalone net profit (PAT) increased 27.1% YoY to ₹407 crore for the June 2026 quarter
• Board approved capital expenditure of ₹1,400 crore for FY27
• Cumulative equity investment in EESL rose to ₹4,902 crore, supported by a ₹100 crore infusion in July 2026
• Bengaluru Phase 1 plant capacity is set at 6 GWh with plans to scale to 12 GWh, targeting first-year capacity utilization of 25% to 30%

What's Changed

• Transition to product evaluation: The greenfield Bengaluru facility transitioned from setup to active testing, completing 100% equipment delivery and commencing customer sample deliveries.
• Equity base expansion: Cumulative funding in subsidiary EESL stepped up to ₹4,902 crore following the latest ₹100 crore infusion in July 2026.

Key Takeaways

• Stellar core base: Strong double-digit expansion in the lead-acid replacement and industrial backup segments acts as a financial anchor, shielding the company from external leverage.
• Commercial timeline on target: Trial deliveries of cylindrical NMC and prismatic LFP cells are underway, supporting expectations of commercial revenue flow starting Q3 FY27.
• Conservative funding model: The high capex required for Phase 1 cell manufacturing continues to be funded via internal cash flows, avoiding margin-dilutive equity raises.

SAHI Perspective

Exide's dual-engine model is working effectively. Core lead-acid operations continue to generate strong, predictable cash flows that safely fund its green energy expansion without heavy debt burdens. However, standardizing battery validation cycles and locking in firm volume contracts with top-tier EV and two-wheeler OEMs will decide how rapidly the new facility translates capacity into operating margins.

Market Implications

Exide's initial commercial traction from its 6 GWh facility can accelerate import substitution for local battery pack manufacturers, lowering the landed cell costs. While peers are also expanding, Exide holds an execution lead that positions it as a major beneficiary of the transition to domestic sourcing.

Trading Signals

Market Bias: Bullish

Supported by standalone PAT rising 27.1% YoY to ₹407 crore and revenue touching ₹5,305 crore, Exide's financial health remains strong. Immediate milestones around gigafactory commercialization provide near-term triggers.

Overweight: Auto Ancillaries, Battery Manufacturers, Clean Energy

Trigger Factors:

• Announcement of definitive purchase agreements with major passenger and two-wheeler OEMs.
• Commencement of commercial revenues from the Bengaluru plant in Q3 FY27.
• Operational scaling toward the targeted 25% to 30% first-year capacity utilization.

Time Horizon: Medium-term (3-12 months)

Industry Context

The battery and energy storage sector in India is rapidly localizing. Government efforts, such as re-opening the 10 GWh ACC PLI scheme and modifying basic import duties on lithium-ion cells, are encouraging domestic cell construction. Top players like Exide are building customized chemistries to secure localized OEM requirements and reduce reliance on Chinese supply chains.

Key Risks to Watch

• Validation timelines: Extended trial and verification periods by automotive OEMs could push back the utilization ramp-up.
• Partnership bottlenecks: Delays in customized production initiatives, such as the localization project with Hyundai-Kia, could impact specific vehicle program timelines.
• Raw material volatility: Sharp fluctuations in essential cell minerals like lithium and cobalt could pressure operating margins.

Recent Developments

Exide Energy Solutions Limited (EESL) successfully completed its BIS and UN 38.3 product certifications. Additionally, management confirmed that its battery cell localization project with Hyundai and Kia is progressing as a parallel co-investment initiative, with commercial launch scheduled beyond FY27.

Closing Insight

Exide is successfully navigating its capital-heavy transition, utilizing its lead-acid base to launch a clean energy business. The focus now shifts from installation to customer validation and commercial contract scaling.

High Performance Trading with SAHI.